Adcock Ingram

Adcock Ingram
Formerly	EJ Adcock Pharmacy (at founding)
Type	Public
Traded as	JSE: AIP
Industry	Health Care, Pharmaceuticals
Founded	1890
Headquarters	Johannesburg, South Africa
Area served	South Africa and selected emerging markets (Southern Africa, Ghana, India)
Key people	Andy Hall, CEO; Dorette Neethling, acting-CFO; Clifford Raphiri, Chairman;
Products	Pharmaceuticals and Health Care
Brands	see sections Pharmaceutical brands and Health care brands
Revenue	R7.09 Billion (2019)[1]
Operating income	R883M (2019) [1]
Net income	R662M (2019) [1]
Number of employees	2600 (2019) [2]
Parent	Bidvest Group
Subsidiaries	Adcock Ingram Critical Care; Adcock Ingram pharmaceuticals;
Website	www.adcock.com

Adcock Ingram is a South African pharmaceutical conglomerate listed on the Johannesburg Stock Exchange. Adcock Ingram manufactures and markets healthcare products to both the private and public sectors. The company has self-described as "the Glaxo of South Africa".[3]

Company organization

In 1995, five divisions comprised the company: critical care, pharmaceuticals, consumer products, wholesale products and an international division; the international division was created to manage the compay's first marketing foray outside of South Africa.[3] the international division later disappeared as a transitional unit, leaving the four core units in place.

The company's office in Leicester, England was established in August 1993, with a staff of two people.[3]

Jonathan Louw led the company's pharmaceuticals division from 2002, at which time the company's CEO was Mike Norris.[4]^:8 Louw became the firm's CEO in 2006, and Norris retired shortly thereafter.[4]^:9 Louw continued as CEO until at least 2013.[5]^:70

History

Adcock Ingram started as a pharmacy in Krugersdorp operating under the name EJ Adcock Pharmacy in 1890.[3][4]^:8 Krugersdorp at the turn of the century was a "bustling pioneer town".[5]^:42 In the early 1900s, Hyme Tannenbaum was apprenticed to then owner, Jack Blair. Hyme's brothers Jack, Len and Archie soon followed him into the pharmacy, which they eventually bought. Beginning with this one small pharmacy, the Tannenbaum brothers built a cross-country chain of retail pharmacies, a pharmaceutical and toiletry manufacturing giant and a highly respected South African success story.[6] Adcock Ingram was first listed on the Johannesburg Stock Exchange in 1950,[4]^:8 the first pharmaceutical company to list on the exchange.[5]^:62

The company began internationalisation in the 1990s, beginning with the United Kingdom and Australia, the former meant to be a springboard into Europe.[3]

The company was sold to Tiger Brands for R3.4 billion,[7] and became a wholly owned subsidiary in 2000.[4]^:8 However, Adcock had been considered a subsidiary of Tiger Brands since 1978.[4]^:8 The relationship with Tiger Brands enabled acquisitions in the 1980s such as the Mer-National division of Dow Chemicals Africa; a 40% share of Baxter's Critical Care Division; and acquisitions of Restan Laboratories and the South African interests of Sterling Winthrop.[4]^:8 The company's acquisitions continued into the 1990s with Lepping, Laser, Pharmatech, Zurich Pharmaceuticals, Covan Pharmaceuticals and Salters.[4]^:8 A merger between Adcock and Premier Pharmaceuticals took place in 1996, which placed Adcock as "the leading supplier of health care products in South Africa."[4]^:8 2001 saw Adcock's acquisition of medical diagnostics firm Steri-Lab, and Robertsons Homecare's acquisition came in 2003.[4]^:8

By 2005, Adcock revenues constituted half of all revenues for parent firm Tiger Brands.[4]^:9 However, growing friction between Adcock's portfolio and the strategic direction charted by Tiger led to Tiger's effective termination in investment in Adcock, which eventually led to divestment of Adcock in 2008, which was shortly followed by Adcock's relisting on the JSE exchange as an independent firm.[4]^:9

Pharmaceutical brands

Pharmaceuticals

Adco-Alzam
Adco-Ciprin
Adco-Dermed
Adco-Dol
Adco-Napacod
Adco-Salterpayne Syrup
Adco-Simvastatin
An extensive range of generic antiretroviral products
Alcophyllex
Aldomet
Allergex
Betapyn
Bron-Cleer
Cepacol
Citro Soda
Clomid
Compral
Corenza C[5]^:72
Eetless
Gen-Payne
Iliadin nose spray
Ladazol
Lentogesic
Mayogel
Medi-Keel A
Mypaid
Myprodol[5]^:72
Nebilet
Panado, tablet for headache relief[5]^:69
Panado Syrup
Prelone
Propain Forte
Proscar
Puritone
Pynstop
Saltermox
Salterpyn
Stopayne
Spersadex Comp eye drops
Spersallerg eye drops
Teargel
Teejel
Uniphyl
Urizone
Veltex
Vomifene
Xylotox
Zocor
Zyloric

Panado (paracetamol) 500 mg tablets

Health supplements

Bioplus, an energy supplement[8][5]^:69
Efamol
Lemplus[3]
Liviton
Probiflora, a probiotic[5]^:69
Vita-Thion

Research supplies

cell culture media and supplements[9]

Health care brands

Hospital business

Sabax Intravenous Fluids
Gambro Haemodialysis
Colleague Infusion Pumps
Adco - Generic Injectables
Oliclinomel Nutrition Range
Fosrenol
Aranesp
Fenwal
One Alpha

Consumer brands

Gill (cosmetic, skin and hair care)[3]
Jet'aime (deodorant)[3]
Nice to Touch (skin care)[3]

References

"Group Annual Financial Statement 2019" (PDF). Adcock Ingram. Retrieved 21 May 2020.
"Bidvest now in control of Adcock Ingram as stake increases to 50%". 7 August 2019.
Staff (3 June 1995). "Breaking Down the Barrier". Chemist & Druggist. Vol. 243 no. 5986. Miller Freeman (United News & Media). pp. 896–7. Retrieved 17 November 2019 – via Internet Archive.
Lew, Charlene C. (2013). "Adcock Ingram: Decisions and Motives That Steer Acquisitions". In Rowe, W. Glenn; Guerrero, Laura (eds.). Cases in Leadership (3rd ed.). Sage Publications. ISBN 9781452234977 – via Google Books (Preview).
Rose, Rob (2013). The Grand Scam: How Barry Tannenbaum Conned South Africa's Business Elite. Cape Town, South Africa: Zebra Press, an imprint of Random House Struik. ISBN 9781770226227 – via Google Books (Preview).
"A look back at 120 years of progress". Essential Publishing. 28 October 2010. Archived from the original on 15 August 2011.
Anderson, Belinda (7 October 1999). "Africa: Tiger Oats Bids For All". Business Day. Retrieved 17 November 2019 – via AllAfrica.
Staff (18 June 1994). "Major South African player embarks on UK". Chemist & Druggist. Vol. 241 no. 5937. United Newspapers. p. 1065. Retrieved 17 November 2019 – via Internet Archive.
Legobo KW, Mokgotho MP, Bagla VP, Matsebatlela TM, Mbazima V, Shai LJ, Mampuru L (2014). "Semi-purified extracts of Commelina benghalensis (Commelinaceae) induce apoptosis and cell cycle arrest in Jurkat-T cells". BMC Complementary and Alternative Medicine. 14 (1): 65. doi:10.1186/1472-6882-14-65. PMC 3941970. PMID 24555704.